相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The relation between the placebo response, observed treatment effect, and failure to meet primary endpoint: A systematic review of clinical trials of preventative pharmacological migraine treatments
Kathryn Evans et al.
CEPHALALGIA (2021)
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study
Shuu-Jiun Wang et al.
CEPHALALGIA (2021)
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
Fumihiko Sakai et al.
HEADACHE (2021)
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
Fumihiko Sakai et al.
HEADACHE (2021)
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina et al.
CEPHALALGIA (2020)
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Richard B. Lipton et al.
NEUROLOGY (2020)
Monoclonal antibodies as a preventive therapy for migraine: A meta-analysis
Yousef Waleed Alasad et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Efficacy and Contextual (Placebo) Effects of CGRP Antibodies for Migraine: Systematic Review and Meta-analysis
Raeburn B. Forbes et al.
HEADACHE (2020)
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention
J. Schoenen et al.
REVUE NEUROLOGIQUE (2020)
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
Wim M. Mulleners et al.
LANCET NEUROLOGY (2020)
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
David W. Dodick et al.
CEPHALALGIA (2019)
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Michel D. Ferrari et al.
LANCET (2019)
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults
Fumihiko Sakai et al.
HEADACHE (2019)
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco et al.
JOURNAL OF HEADACHE AND PAIN (2019)
CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis
Lin Han et al.
BRAIN AND BEHAVIOR (2019)
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Vladimir Skljarevski et al.
CEPHALALGIA (2018)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine
Uwe Reuter
HEADACHE (2018)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial
David W. Dodick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
CGRP as the target of new migraine therapies - successful translation from bench to clinic
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention A Randomized Clinical Trial
Vladimir Skljarevski et al.
JAMA NEUROLOGY (2018)
The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis
Yuhan Zhu et al.
NEUROLOGICAL SCIENCES (2018)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Uwe Reuter et al.
LANCET (2018)
Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
Holland C. Detke et al.
NEUROLOGY (2018)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
Andre Leite Goncalves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Drug safety and tolerability in prophylactic migraine treatment
Laszlo Vecsei et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Antiepileptics in migraine prophylaxis: An updated Cochrane review
Wim M. Mulleners et al.
CEPHALALGIA (2015)
Adherence to oral migraine-preventive medications among patients with chronic migraine
Zsolt Hepp et al.
CEPHALALGIA (2015)
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
Lars J. Stovner et al.
CEPHALALGIA (2014)
Systematic Review of Migraine Prophylaxis Adherence and Persistence
Zsolt Hepp et al.
JOURNAL OF MANAGED CARE PHARMACY (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults
Mattias Linde et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
Peer Tfelt-Hansen et al.
CEPHALALGIA (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
The safety and efficacy of occipital nerve stimulation for the management of chronic migraine
S. Silberstein et al.
CEPHALALGIA (2011)
Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache
James R. Couch
HEADACHE (2011)
Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study
Richard B. Lipton et al.
CEPHALALGIA (2011)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. K. Aurora et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick et al.
HEADACHE (2010)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients
Marina de Tommaso et al.
NEUROSCIENCE LETTERS (2008)
Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study
M. Siniatchkin et al.
CEPHALALGIA (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
Stephen D. Silberstein et al.
HEADACHE (2007)
Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine With/Without aura in adults: A randomized, placebo-controlled, double-blind, 12-week pilot study
Stephen D. Silberstein et al.
CLINICAL THERAPEUTICS (2006)
Topiramate in migraine prevention - Results of a large controlled trial
SD Silberstein et al.
ARCHIVES OF NEUROLOGY (2004)
Topiramate for migraine prevention - A randomized controlled trial
JL Brandes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control
HC Diener et al.
JOURNAL OF NEUROLOGY (2004)
Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
D Mei et al.
NEUROLOGICAL SCIENCES (2004)
Topiramate in the treatment of chronic migraine
M Silvestrini et al.
CEPHALALGIA (2003)
Prophylactic treatment of migraine with an angiotensin II receptor blocker - A randomized controlled trial
E Tronvik et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis
FG Freitag et al.
NEUROLOGY (2002)
Topiramate in migraine prevention: A double-blind, placebo-controlled study
JR Storey et al.
HEADACHE (2001)
分享论文
